| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...873866L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0073866 |
| P932 | PMC publication ID | 3765253 |
| P698 | PubMed publication ID | 24040099 |
| P5875 | ResearchGate publication ID | 256614312 |
| P2093 | author name string | Yanling Wu | |
| Zhengping Zhuang | |||
| Chunzhang Yang | |||
| Weimin Wang | |||
| Ying Lu | |||
| Hai Hu | |||
| Zhongmin Liu | |||
| Junyi Han | |||
| Zengguang Xu | |||
| Junchen Wang | |||
| Huiming Mao | |||
| Xuelian Fu | |||
| Bingguan Chen | |||
| Jingping Cai | |||
| P2860 | cites work | A gene atlas of the mouse and human protein-encoding transcriptomes | Q24568043 |
| mTOR signaling in growth control and disease | Q24634174 | ||
| Polyamines and cancer: implications for chemotherapy and chemoprevention | Q26864516 | ||
| Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase | Q28288793 | ||
| Sustained nitric oxide production in macrophages requires the arginine transporter CAT2 | Q28509396 | ||
| mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase | Q29616153 | ||
| Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. | Q33763653 | ||
| Almost all about citrulline in mammals | Q33989190 | ||
| Polyamines and cancer: old molecules, new understanding | Q34362757 | ||
| Colorectal cancer molecular biology moves into clinical practice | Q34425013 | ||
| Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening | Q34438218 | ||
| miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. | Q34592976 | ||
| Polyamines upregulate the mRNA expression of cationic amino acid transporter-1 in human retinal pigment epithelial cells | Q34627223 | ||
| Increased uptake of amino acids and 2-deoxy-D-glucose by virus-transformed cells in culture | Q34692279 | ||
| Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. | Q53585030 | ||
| Characterization and growth factor stimulation of L-arginine transport in a human colon cancer cell line | Q71973642 | ||
| Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion | Q79518349 | ||
| Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression | Q34784897 | ||
| Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer | Q35541869 | ||
| L-arginine availability regulates T-lymphocyte cell-cycle progression | Q35628850 | ||
| Plasma membrane transporters for arginine | Q35909702 | ||
| The role of nitric oxide in tumour progression | Q36516414 | ||
| Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones | Q36545633 | ||
| Report of incidence and mortality in China cancer registries, 2009. | Q36563233 | ||
| Targeted therapies in colorectal cancer-an integrative view by PPPM | Q36646911 | ||
| Structure and function of cationic amino acid transporters (CATs). | Q36785025 | ||
| Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases | Q36803757 | ||
| Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis | Q37068792 | ||
| Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives | Q37118164 | ||
| Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation | Q37152797 | ||
| Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis | Q37161838 | ||
| Arginine metabolism and nutrition in growth, health and disease | Q37179500 | ||
| Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk | Q37370572 | ||
| A bifunctional intronic element regulates the expression of the arginine/lysine transporter Cat-1 via mechanisms involving the purine-rich element binding protein A (Pur alpha). | Q37431928 | ||
| CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines | Q39594935 | ||
| Tumour maintenance is mediated by eNOS. | Q40001801 | ||
| A method to study apoptosis in eosinophils by flow cytometry | Q42489182 | ||
| Transcriptional control of the arginine/lysine transporter, cat-1, by physiological stress. | Q42610027 | ||
| Arginine: master and commander in innate immune responses | Q42934795 | ||
| Simultaneous determination of l-citrulline and l-arginine in plasma by high performance liquid chromatography | Q43029223 | ||
| Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation | Q43805340 | ||
| Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo | Q44164578 | ||
| L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma | Q46840506 | ||
| Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction | Q46925513 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell growth | Q189159 |
| colorectal cancer | Q188874 | ||
| colorectal carcinoma | Q25493920 | ||
| overexpression | Q61643320 | ||
| P304 | page(s) | e73866 | |
| P577 | publication date | 2013-09-06 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue | |
| P478 | volume | 8 |
| Q94562053 | Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy |
| Q42362675 | Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies |
| Q90604494 | Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes |
| Q91871570 | Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability |
| Q37687381 | Co-application of canavanine and irradiation uncouples anticancer potential of arginine deprivation from citrulline availability |
| Q47162078 | Degradation of AMPK-α1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation |
| Q41574368 | Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery. |
| Q40202441 | Genetic variation in SLC7A2 interacts with calcium and magnesium intakes in modulating the risk of colorectal polyps |
| Q99234034 | L-Arginine prevents cereblon-mediated ubiquitination of glucokinase and stimulates glucose-6-phosphate production in pancreatic β-cells |
| Q38749541 | Molecular basis and current strategies of therapeutic arginine depletion for cancer. |
| Q39028088 | More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer. |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q50585708 | Technetium-99m complexes of l-arginine derivatives for targeting amino acid transporters. |
Search more.